World's Best Scientists 2026 revealed!
Award Badge
Medicine
Belgium
2026
Award Badge
Microbiology
Belgium
2026

D-Index & Metrics

Microbiology

D-Index
155
Citations
112082
World Ranking
22
National Ranking
1

Medicine

D-Index
157
Citations
118490
World Ranking
875
National Ranking
9

Erik De Clercq publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Erik De Clercq sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 1,960 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Erik De Clercq D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Erik De Clercq sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 155 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Belgium Leader Award
  • 2026 - Research.com Microbiology in Belgium Leader Award
  • 2025 - Research.com Medicine in Belgium Leader Award
  • 2025 - Research.com Microbiology in Belgium Leader Award
  • 2023 - Research.com Microbiology in Belgium Leader Award
  • 2022 - Research.com Microbiology in Belgium Leader Award
  • 2010 - Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson for his landmark discoveries in anti-HIV medications, including nucleotide analogues, and inventions or co-inventions of several approved drugs for anti-viral therapy.
  • 1994 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1989 - Member of Academia Europaea

Overview

Erik De Clercq is affiliated with the Rega Institute for Medical Research in Belgium. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on infectious diseases and virology. The scientist's work is closely associated with the development and treatment of HIV/AIDS, alongside topics such as Pneumocystis jirovecii pneumonia detection and treatment, and hepatitis C virus research.

The main subjects of their research include:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Click Chemistry and Applications
  • Biochemical and Molecular Research
  • Hepatitis C virus research
  • HIV/AIDS Research and Interventions

Erik De Clercq has contributed to numerous scientific articles, with recent papers including:

  • "Therapeutic options for the 2019 novel coronavirus (2019-nCoV)", 2020, Nature Reviews Drug Discovery
  • "Therapeutic strategies for COVID-19: progress and lessons learned", 2023, Nature Reviews Drug Discovery
  • "Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses", 2021, Chemical Society Reviews
  • "Clinical significance of chemokine receptor antagonists", 2020, Expert Opinion on Drug Metabolism & Toxicology
  • "Approved HIV reverse transcriptase inhibitors in the past decade", 2021, Acta Pharmaceutica Sinica B

Collaborations with other researchers are a notable feature of their academic activity. Frequent coauthors include:

  • Christophe Pannecouque
  • Xinyong Liu
  • Dongwei Kang
  • Peng Zhan
  • Fen-Er Chen

Publications by Erik De Clercq have appeared repeatedly in several scientific journals, with the highest number of papers found in:

  • European Journal of Medicinal Chemistry
  • Journal of Medicinal Chemistry
  • Bioorganic Chemistry
  • Acta Pharmaceutica Sinica B
  • Molecules

Their work has earned recognition through awards such as the Dr. Paul Janssen Award for Biomedical Research by Johnson & Johnson in 2010, which cites contributions to anti-HIV medications and antiviral drug development. They were elected as a Fellow of the American Association for the Advancement of Science (AAAS) in 1994 and became a Member of the Academia Europaea in 1989.

Best Publications

  • Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

    Rudi Pauwels;Jan Balzarini;Masanori Baba;Robert Snoeck

  • Approved Antiviral Drugs over the Past 50 Years

    Erik De Clercq;Guangdi Li;Guangdi Li

  • Therapeutic options for the 2019 novel coronavirus (2019-nCoV).

    Guangdi Li;Erik De Clercq

  • Angiogenesis : regulators and clinical applications

    Sandra Liekens;Erik De Clercq;Johan Neyts

  • Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

    Rudi Pauwels;Koen Andries;Jan Desmyter;Dominique Schols

  • A novel selective broad-spectrum anti-DNA virus agent.

    Erik De Clercq;Antonin Holý;Ivan Rosenberg;Takashi Sakuma

  • Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections.

    Erik De Clercq

  • Antiviral agents active against influenza A viruses

    Erik De Clercq

  • HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells

    Peter Cherepanov;Goedele Maertens;Paul Proost;Bart Devreese

  • Strategies in the design of antiviral drugs

    Erik De Clercq

  • Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

    Erik De Clercq

  • Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4

    Dominique Schols;Sofie Struyf;Jo Van Damme;José A. Esté

  • Therapeutic strategies for COVID-19: progress and lessons learned

    Unknown

  • Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines.

    Erik De Clercq;Takashi Sakuma;Masanori Baba;Rudi Pauwels

  • Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy

    Leen De Bolle;Lieve Naesens;Erik De Clercq

  • The bicyclam AMD3100 story

    Erik De Clercq

  • Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

    Sigrid Hatse;Katrien Princen;Gary Bridger;Erik De Clercq

  • LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells

    Goedele Maertens;Peter Cherepanov;Willem Pluymers;Katrien Busschots

  • A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.

    Tadashi Miyasaka;Hiromichi Tanaka;Masanori Baba;Hiroyuki Hayakawa

  • Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection

    Erik De Clercq

  • Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro

    Masanori Baba;Rudi Pauwels;Piet Herdewijn;Erik De Clercq

  • Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later

    Christophe Pannecouque;Dirk Daelemans;Erik De Clercq

  • Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives.

    Aliasghar Jarrahpour;Dariush Khalili;Erik De Clercq;Chanaz Salmi

  • Synthesis and biological activity of 4-thiazolidinones, thiosemicarbazides derived from diflunisal hydrazide

    Güniz Küçükgüzel;Ayla Kocatepe;Erik De Clercq;Fikrettin Şahin;Fikrettin Şahin

  • Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.

    Masaihiko Ito;Masanori Baba;Akihiko Sato;Rudi Pauwels

  • Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy

    Erik De Clercq;Hugh J Field

Frequent Co-Authors

Jan Balzarini
Jan Balzarini KU Leuven
Christophe Pannecouque
Christophe Pannecouque Rega Institute for Medical Research
Robert Snoeck
Robert Snoeck KU Leuven
Johan Neyts
Johan Neyts Rega Institute for Medical Research
Xinyong Liu
Xinyong Liu Shandong University
Peng Zhan
Peng Zhan Shandong University
Lieve Naesens
Lieve Naesens Rega Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related fields, especially within healthcare and information management. For students interested in blending science with data, pursuing an online degree in health information management can be a strategic choice. Programs that are cahiim accredited health information management programs online ensure quality education aligned with industry standards.

Career prospects in this sector often include roles like health information managers, where understanding the field’s scope can boost career decisions. For those curious about compensation, the health information management salary offers insight into the earning potential and growth opportunities available.

For quicker entry into healthcare administration, the shortest online medical billing and coding certificate programs provide accelerated pathways to certification and work readiness.

Additionally, those pursuing broader healthcare roles can explore medical programs online that complement microbiology knowledge and lead to diverse medical careers. Overall, combining microbiology with these related degrees offers flexible, impactful career pathways.

Best Scientists Citing Erik De Clercq

Trending Scientists

Recently Published Articles